<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">95576</article-id>
<article-id pub-id-type="doi">10.7554/eLife.95576</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.95576.4</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.4</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Cell Biology</subject>
</subj-group>
</article-categories><title-group>
<article-title>Axonal distribution of mitochondria maintains neuronal autophagy during aging via eIF2β</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0002-7114-7686</contrib-id>
<name>
<surname>Shinno</surname>
<given-names>Kanako</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miura</surname>
<given-names>Yuri</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iijima</surname>
<given-names>Koichi M</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suzuki</surname>
<given-names>Emiko</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3956-276X</contrib-id>
<name>
<surname>Ando</surname>
<given-names>Kanae</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a6">6</xref>
<email>k_ando@tmu.ac.jp</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00ws30h19</institution-id><institution>Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rd0p893</institution-id><institution>Research Team for Mechanism of Aging, Tokyo Metropolitan Institute for Geriatrics and Gerontology</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05h0rw812</institution-id><institution>Department of Alzheimer’s Disease Research, National Center for Geriatrics and Gerontology</institution></institution-wrap>, <city>Ōbu</city>, <country country="JP">Japan</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04wn7wc95</institution-id><institution>Department of Experimental Gerontology, Graduate School of Pharmaceutical Sciences, Nagoya City University</institution></institution-wrap>, <city>Nagoya</city>, <country country="JP">Japan</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02xg1m795</institution-id><institution>Gene Network Laboratory, National Institute of Genetics and Department of Genetics, SOKENDAI</institution></institution-wrap>, <city>Mishima</city>, <country country="JP">Japan</country></aff>
<aff id="a6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00ws30h19</institution-id><institution>Department of Biological Sciences, School of Science, Tokyo Metropolitan University</institution></institution-wrap>, <city>Tokyo</city>, <country country="JP">Japan</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Frost</surname>
<given-names>Adam</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of California, San Francisco (Adjunct)</institution>
</institution-wrap>
<city>San Francisco</city>
<country country="US">United States</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Kapahi</surname>
<given-names>Pankaj</given-names>
</name>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5629-4947</contrib-id><role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/050sv4x28</institution-id><institution>Buck Institute for Research on Aging</institution>
</institution-wrap>
<city>Novato</city>
<country country="US">United States</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1"><label>†</label><p>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Chikusa-Ku, Nagoya, Aichi, 464-8601, Japan</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-03-25">
<day>25</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2025-10-31">
<day>31</day>
<month>10</month>
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP95576</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-01-16">
<day>16</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-01-20">
<day>20</day>
<month>01</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.01.20.576435"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2024-03-25">
<day>25</day>
<month>03</month>
<year>2024</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.95576.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.95576.1.sa2">eLife Assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.95576.1.sa1">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.95576.1.sa0">Reviewer #2 (Public Review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.95576.1.sa3">Author Response</self-uri>
</event>
<event>
<event-desc>Reviewed preprint v2</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2025-01-23">
<day>23</day>
<month>01</month>
<year>2025</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.95576.2"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.95576.2.sa3">eLife Assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.95576.2.sa2">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.95576.2.sa1">Reviewer #2 (Public Review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.95576.2.sa0">Author response:</self-uri>
</event>
<event>
<event-desc>Reviewed preprint v3</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2025-09-12">
<day>12</day>
<month>09</month>
<year>2025</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.95576.3"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.95576.3.sa3">eLife Assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.95576.3.sa2">Reviewer #1 (Public review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.95576.3.sa1">Reviewer #2 (Public review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.95576.3.sa0">Author response:</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Shinno et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Shinno et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-95576-v4.pdf"/>
<abstract>
<p>Neuronal aging and neurodegenerative diseases are accompanied by proteostasis collapse, while the cellular factors that trigger it have not been identified. Impaired mitochondrial transport in the axon is another feature of aging and neurodegenerative diseases. Using <italic>Drosophila</italic>, we found that genetic depletion of axonal mitochondria causes dysregulation of protein degradation. Axons with mitochondrial depletion showed abnormal protein accumulation and autophagic defects. Lowering neuronal ATP levels by blocking glycolysis did not reduce autophagy, suggesting that autophagic defects are associated with mitochondrial distribution. We found that eIF2β was increased by the depletion of axonal mitochondria via proteome analysis. Phosphorylation of eIF2α, another subunit of eIF2, was lowered, and global translation was suppressed. Neuronal overexpression of <italic>eIF2</italic>β phenocopied the autophagic defects and neuronal dysfunctions, and lowering <italic>eIF2</italic>β expression rescued those perturbations caused by depletion of axonal mitochondria. These results indicate the mitochondria-eIF2β axis maintains proteostasis in the axon, of which disruption may underlie the onset and progression of age-related neurodegenerative diseases.</p>
</abstract>
<abstract abstract-type="summary">
<title>Highlights</title>
<list list-type="bullet">
<list-item><p>Loss of axonal mitochondria impairs autophagy and accumulates proteins in the axon</p></list-item>
<list-item><p>Loss of axonal mitochondria increases eIF2β and decreases p-eIF2α</p></list-item>
<list-item><p>Neuronal upregulation of eIF2β induces autophagic defects and locomotor dysfunction</p></list-item>
<list-item><p>Lowering eIF2β rescues autophagic defects caused by loss of axonal mitochondria</p></list-item>
</list>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Mitochondria</kwd>
<kwd>axonal transport</kwd>
<kwd>aging</kwd>
<kwd>neuronal proteostasis</kwd>
<kwd>protein aggregation</kwd>
<kwd>autophagy</kwd>
<kwd>eukaryotic Initiation Factor 2β (eIF2β)</kwd>
<kwd><italic>Drosophila</italic></kwd>
<kwd>neurodegeneration</kwd>
<kwd>proteome</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution>Sasakawa Scientific Research Grant</institution>
</institution-wrap>
</funding-source>
<award-id>2021-4087</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/045d4st33</institution-id>
<institution>Yoga Science Foundation</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="funding-3">
<funding-source>
<institution-wrap>
<institution>Hoansha foundation grant</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="funding-4">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/04yc0k443</institution-id>
<institution>Japan Foundation for Aging and Health</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="funding-5">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/04yanv433</institution-id>
<institution>Novartis Foundation (Japan) for the promotion of Science</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="funding-6">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id>
<institution>Japan Society for the Promotion of Science</institution>
</institution-wrap>
</funding-source>
<award-id>JP19K21593</award-id>
</award-group>
<award-group id="funding-6a">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id>
<institution>Japan Society for the Promotion of Science</institution>
</institution-wrap>
</funding-source>
<award-id>JP24K02860</award-id>
</award-group>
<award-group id="funding-7">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/02xg1m795</institution-id>
<institution>National Institute of Genetics</institution>
</institution-wrap>
</funding-source>
<award-id>NIG-JOINT 71A2018</award-id>
</award-group>
<award-group id="funding-7a">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/02xg1m795</institution-id>
<institution>National Institute of Genetics</institution>
</institution-wrap>
</funding-source>
<award-id>NIG-JOINT 25A2019</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Fig 1a was corrected. Figure order was corrected.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Neurons have a morphologically complex architecture composed of microcompartments and require tight regulation of the abundance of proteins and organelles spatially and temporally<sup><xref ref-type="bibr" rid="c1">1</xref></sup>. Such control of protein amounts, or proteostasis, is essential for neuronal functions<sup><xref ref-type="bibr" rid="c2">2</xref></sup> and is achieved through the orchestration of protein expression, folding, trafficking, and degradation controlled by intrinsic and environmental signals<sup><xref ref-type="bibr" rid="c3">3</xref></sup>. Translation is initiated by the eukaryotic initiation factor 2 (eIF2) complex<sup><xref ref-type="bibr" rid="c4">4</xref></sup>. eIF2, a heterotrimer of α, β, and γ subunits, transports Met-tRNA to the ribosome in a GTP-dependent manner<sup><xref ref-type="bibr" rid="c5">5</xref></sup>. Under stressed conditions, phosphorylation of eIF2α attenuates global translation and initiates translation of mRNAs related to the integrated stress response (ISR)<sup><xref ref-type="bibr" rid="c6">6</xref></sup>. As for protein degradation, autophagy and proteasome are major systems that maintain proteostasis<sup><xref ref-type="bibr" rid="c7">7</xref></sup>. The proteasome degrades unnecessary proteins, followed by regulated ubiquitination processes<sup><xref ref-type="bibr" rid="c8">8</xref></sup>, and autophagy removes damaged or harmful components, including large protein aggregates and organelles, through catabolism (selective autophagy)<sup><xref ref-type="bibr" rid="c9">9</xref></sup>. In addition to autophagy induced by acute stressors, a basal level of selective autophagy mediates the global turnover of damaged proteins<sup><xref ref-type="bibr" rid="c10">10</xref></sup>.</p>
<p>Such constitutive autophagy decreases during aging, which may underlie declines in the structural and functional integrity of neurons<sup><xref ref-type="bibr" rid="c11">11</xref></sup>. Decreased protein degradation and accumulation of abnormal proteins also contribute to increased risks of neurodegenerative diseases. Age-related neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease are often associated with the accumulation of misfolded proteins such as amyloid-β, tau, and α-synuclein<sup><xref ref-type="bibr" rid="c12">12</xref></sup>. Enhancement of autophagy mitigates age-related dysfunctions and neurodegeneration caused by proteotoxic stress<sup><xref ref-type="bibr" rid="c13">13</xref></sup>. However, it is not fully understood how aging disrupts the regulation of this constitutive autophagy.</p>
<p>Neurons are also highly energy-demanding cells. At nerve terminals, action potentials trigger the release of neurotransmitters via exocytosis of synaptic vesicles, which requires a constant supply of ATP and calcium buffering<sup><xref ref-type="bibr" rid="c14">14</xref></sup>. Such neuronal activity relies on mitochondrial functions<sup><xref ref-type="bibr" rid="c15">15</xref></sup>, and mitochondria are actively transported from their major sites of biogenesis in soma to axons<sup><xref ref-type="bibr" rid="c16">16</xref></sup>. However, the axonal transport of mitochondria declines during aging<sup><xref ref-type="bibr" rid="c17">17</xref>,<xref ref-type="bibr" rid="c18">18</xref>,<xref ref-type="bibr" rid="c19">19</xref></sup>. Reduced axonal transport of mitochondria is thought to contribute to age-related declines in neuronal functions<sup><xref ref-type="bibr" rid="c17">17</xref>,<xref ref-type="bibr" rid="c19">19</xref>,<xref ref-type="bibr" rid="c20">20</xref>,<xref ref-type="bibr" rid="c21">21</xref></sup>. The number of functional mitochondria in synapses is reduced in the brains of patients suffering from age-related neurodegenerative diseases such as Alzheimer’s disease<sup><xref ref-type="bibr" rid="c22">22</xref></sup>, and mutations in genes involved in mitochondrial dynamics are linked to neurodegenerative diseases<sup><xref ref-type="bibr" rid="c23">23</xref></sup>. The mislocalization of mitochondria is sufficient to cause age-dependent neurodegeneration in <italic>Drosophila</italic> and mice<sup><xref ref-type="bibr" rid="c24">24</xref>,<xref ref-type="bibr" rid="c25">25</xref></sup>, indicating that the proper distribution of mitochondria is essential to maintain neuronal functions. Thus, depletion of functional mitochondria from axons and proteostasis collapse are common features of aging and neurodegenerative diseases.</p>
<p>Mitochondrial transport is regulated by a series of molecular adaptors that mediate the attachment of mitochondria to molecular motors<sup><xref ref-type="bibr" rid="c16">16</xref></sup>. In <italic>Drosophila</italic>, mitochondrial transport is mediated by milton and Miro, which attaches mitochondria to microtubules via kinesin heavy chain<sup><xref ref-type="bibr" rid="c26">26</xref>,<xref ref-type="bibr" rid="c27">27</xref></sup>. In the absence of milton or Miro, synaptic terminals and axons lack mitochondria, although mitochondria are numerous in the neuronal cell body<sup><xref ref-type="bibr" rid="c28">28</xref></sup>. We previously reported that RNAi-mediated knockdown of <italic>milton</italic> or <italic>Miro</italic> in neurons causes a reduction in axonal mitochondria, age-dependent locomotor defects<sup><xref ref-type="bibr" rid="c29">29</xref></sup>, and age-dependent neurodegeneration in neuropile area starting around 30 days after eclosion (day-old)<sup><xref ref-type="bibr" rid="c24">24</xref></sup>, and enhances axon degeneration caused by human tau proteins<sup><xref ref-type="bibr" rid="c24">24</xref></sup>, suggesting that these flies can be used as a model to analyze the effect of depletion of axonal mitochondria during aging. In this study, we investigated a causal relationship between mitochondrial distribution and neuronal proteostasis by using neuronal knockdown of <italic>milton</italic>. We found that depletion of axonal mitochondria reduced autophagy and increased the accumulation of aggregated proteins in the axon prior to gross neurodegeneration. Proteome analysis and follow-up biochemical analyses revealed that neuronal knockdown of <italic>milton</italic> increased eIF2β levels and lowered phosphorylation of eIF2αin the axon. In addition, <italic>milton</italic> knockdown suppressed global translation. Overexpression of <italic>eIF2</italic>β was sufficient to decrease autophagy and induce neuronal dysfunction, and genetic suppression of <italic>eIF2</italic>β restored autophagy and improved neuronal function in the <italic>milton</italic> knockdown background. These findings suggest that loss of axonal mitochondria and elevated levels of eIF2β mediate proteostasis collapse and neuronal dysfunction during aging.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Depletion of axonal mitochondria by knockdown of <italic>milton</italic> or <italic>Miro</italic> causes protein accumulation in the axon</title>
<p>In <italic>Drosophila</italic>, mitochondrial transport is mediated by milton and Miro, which attach mitochondria to microtubules via kinesin heavy chain<sup><xref ref-type="bibr" rid="c26">26</xref>,<xref ref-type="bibr" rid="c27">27</xref></sup> (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). It has been reported that expression of <italic>milton</italic> RNAi in neurons via pan-neuronal elav-GAL4 driver reduced milton protein levels in <italic>Drosophila</italic> head lysate to 40% and mito-GFP signals in axons to 50%<sup><xref ref-type="bibr" rid="c24">24</xref>,<xref ref-type="bibr" rid="c29">29</xref></sup>.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Knockdown of <italic>milton</italic> or <italic>Miro</italic> causes protein accumulation in the axon</title>
<p>(A) Schematic representation of the mitochondrial transport machinery. Knockdown of <italic>milton</italic>, an adapter protein for mitochondrial transport, depletes mitochondria in the axon. (B, C) Ubiquitinated proteins in brains with neuronal knockdown of <italic>milton</italic> or <italic>Miro</italic>. Brains dissected at 14-day-old (B) or 30-day-old (C) were immunostained with an antibody against ubiquitin. Firefly <italic>luciferase</italic> RNAi was used as a control. Representative images (left) and quantitation of the number of ubiquitin-positive puncta (right) are shown. Scale bars of hemibrains, 100 µm, Scale bars of high magnifications, 10 µm. Means ± SE, n = 8. <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05; ***<italic>p</italic> &lt; 0.005 (one-way analysis of variance (ANOVA) followed by Tukey’s honestly significant difference (HSD) <italic>post hoc</italic> test). (D) Cross sections in the lamina and in the retina were used to analyze the ultrastructure of synapses and cell bodies, respectively. <italic>milton</italic> RNAi was expressed in the retina and neurons via a combination of GAL4 drivers, a pan-retinal gmr-GAL4 and pan-neuronal elav-GAL4. (E) Quantitation of the number of mitochondria in a presynaptic terminal from transmission electron micrographs. 180 presynaptic terminals from cross-sections of the lamina from three brains were analyzed. ***<italic>p</italic> &lt; 0.005 (Chi-square test). (F, G) Presynaptic terminals of photoreceptor neurons of control and <italic>milton</italic> knockdown flies. Photoreceptor neurons are highlighted in blue. Swollen presynaptic terminals (asterisks in (F)), characterized by the enlargement and higher circularity, were found more frequently in <italic>milton</italic> knockdown neurons. Arrowheads indicate presynaptic terminals with dense materials. Scale bars, 2 µm. Representative images (Left) and quantitation (Right) are shown. 918–1118 from three heads were quantified for the percentage of swollen presynaptic terminals, and 180 presynaptic terminals from three heads were quantified for the size of presynaptic terminals. Mean ± SE, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.005 (Student’s <italic>t</italic>-test). (G) Dense materials (arrowheads in (G)) in the presynaptic terminals of <italic>milton</italic> knockdown neurons. Scale bars, 2 µm. The ratio of presynaptic terminals containing dense materials were quantified from 918–1118 presynaptic terminals from three heads. Mean ± SE, ***<italic>p</italic> &lt; 0.005 (Student’s <italic>t</italic>-test). (H) Cell bodies of photoreceptor neurons of control and <italic>milton</italic> knockdown flies. Scale bars, 2 µm. Flies were 27-day-old.</p></caption>
<graphic xlink:href="576435v4_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To test how loss of axonal mitochondria affects proteostasis in neurons, we first examined the accumulation of ubiquitinated proteins. At 14-day-old, more ubiquitinated proteins were deposited in the brains of <italic>milton</italic> knockdown flies than in those of age-matched control flies (<xref rid="fig1" ref-type="fig">Figure 1B</xref>, <italic>p</italic> &lt; 0.005 between control RNAi and <italic>milton</italic> RNAi). There was no significant increase in ubiquitinated proteins in <italic>milton</italic> knockdown flies at 1-day old, suggesting that the accumulation of ubiquitinated proteins caused by <italic>milton</italic> knockdown is age-dependent (Figure S1). We also analyzed the effect of the neuronal knockdown of <italic>Miro</italic>, a partner of milton, on the accumulation of ubiquitin-positive proteins. Since severe knockdown of <italic>Miro</italic> in neurons causes lethality, we used UAS-<italic>Miro</italic> RNAi strain with low knockdown efficiency, whose expression driven by elav-GAL4 caused 30% reduction of <italic>Miro</italic> mRNA in head extract<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. Although there was a tendency for increased ubiquitin-positive puncta in <italic>Miro</italic> knockdown brains, the difference was not significant (<xref rid="fig1" ref-type="fig">Figure 1B</xref>, <italic>p</italic>&gt;0.05 between control RNAi and <italic>Miro</italic> RNAi). These data suggest that the depletion of axonal mitochondria induced by <italic>milton</italic> knockdown leads to the accumulation of ubiquitinated proteins before neurodegeneration occurs.</p>
<p>It has been reported that ubiquitinated proteins accumulate with aging<sup><xref ref-type="bibr" rid="c30">30</xref></sup>; thus, we analyzed the accumulation of ubiquitinated proteins in aged brains (30-day-old) with <italic>milton</italic> knockdown. The number of puncta of ubiquitinated proteins did not significantly differ between control and <italic>milton</italic> knockdown flies or between control and <italic>Miro</italic> knockdown flies (<xref rid="fig1" ref-type="fig">Figure 1C</xref>, <italic>p</italic> &gt; 0.05). These results suggest that depletion of axonal mitochondria may have more impact on proteostasis in young neurons than in old neurons.</p>
<p>We examined the ultrastructure of presynaptic terminals and cell bodies in photoreceptor neurons with <italic>milton</italic> knockdown by transmission electron microscopy in 27-day-old flies (<xref rid="fig1" ref-type="fig">Figure 1D</xref>). As previously reported<sup><xref ref-type="bibr" rid="c24">24</xref></sup>, the number of mitochondria in presynaptic terminals decreased in <italic>milton</italic> knockdown (<xref rid="fig1" ref-type="fig">Figure 1E</xref>). The swelling of presynaptic terminals, characterized by the enlargement and roundness, was not reported at 3-day-old<sup><xref ref-type="bibr" rid="c24">24</xref></sup> but observed at this age with about 4% of total presynaptic terminals (<xref rid="fig1" ref-type="fig">Figure 1F</xref>, asterisks).</p>
<p>Some presynaptic terminals of <italic>milton</italic> knockdown neurons contained dense materials (<xref rid="fig1" ref-type="fig">Figure 1F and G</xref>, arrowheads). Dense materials are rarely found in age-matched control neurons, indicating that <italic>milton</italic> knockdown induces abnormal protein accumulation in the presynaptic terminals (<xref rid="fig1" ref-type="fig">Figure 1G and H</xref>). In <italic>milton</italic> knockdown neurons, dense materials are found in swollen presynaptic terminals more often than in presynaptic terminals without swelling, suggesting a positive correlation between the disruption of proteostasis and axonal damage (<xref rid="fig1" ref-type="fig">Figure 1G</xref>). In contrast, dense materials were not observed in cell bodies in the <italic>milton</italic> knockdown retina (<xref rid="fig1" ref-type="fig">Figure 1H</xref>). These results indicate that the depletion of axonal mitochondria induces protein accumulation in the axon.</p>
</sec>
<sec id="s2b">
<title>Depletion of axonal mitochondria impairs protein degradation pathways</title>
<p>Since abnormal proteins were accumulated in <italic>milton</italic> knockdown brains, we next examined if protein degradation pathways were suppressed. We analyzed autophagy via western blotting of the autophagy markers LC3 and p62<sup><xref ref-type="bibr" rid="c31">31</xref></sup>. During autophagy progression, LC3 is conjugated with phosphatidylethanolamine to form LC3-II, which localizes to isolation membranes and autophagosomes. LC3-I accumulation occurs when autophagosome formation is impaired, and LC3-II accumulation is associated with lysosomal defects<sup><xref ref-type="bibr" rid="c31">31</xref>,<xref ref-type="bibr" rid="c32">32</xref></sup>. p62 is an autophagy substrate, and its accumulation suggests autophagic defects<sup><xref ref-type="bibr" rid="c31">31</xref>,<xref ref-type="bibr" rid="c32">32</xref></sup>. We found that <italic>milton</italic> knockdown increased LC3-I, and the LC3-II/LC3-I ratio was lower in <italic>milton</italic> knockdown flies than in control flies at 14-day-old (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). We also analyzed p62 levels in head lysates sequentially extracted using detergents with different stringencies (1% Triton X-100 and 2% SDS). Western blotting revealed that p62 levels were increased in the brains of 14-day-old of <italic>milton</italic> knockdown flies (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). The increase in the p62 level was significant in the Triton X-100-soluble fraction but not in the SDS-soluble fraction (<xref rid="fig2" ref-type="fig">Figure 2B</xref>), suggesting that depletion of axonal mitochondria impairs the degradation of less-aggregated proteins. Proteasome activity was also significantly decreased in brains with neuronal knockdown of <italic>milton</italic> (<xref rid="fig2" ref-type="fig">Figure 2C</xref>, <italic>p</italic> &lt; 0.005).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title><italic>milton</italic> knockdown impairs protein degradation pathways</title><p>(A, B) Western blotting of head extracts of control and <italic>milton</italic> knockdown flies with antibodies against LC3 (A) and Ref2P, the fly homolog of mammalian p62 (B). For the analyses of p62 levels, heads were extracted with 1% Triton X-100 or 2% SDS (B). Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Actin was used as a loading control. Means ± SE, n = 6 (LC3), n = 3 (p62). (C) Proteasome activity in head extracts of control and <italic>milton</italic> knockdown flies was measured by hydrolysis of Suc-LLVY-AMC at 14-day-old. Means ± SE, n = 3. (D, E) Western blotting of head extracts of 30-day-old control and <italic>milton</italic> knockdown flies. Blotting was performed with anti-LC3 (D) and anti-p62 (E) antibodies. Representative blots (left) and quantitation (right) are shown. Actin was used as a loading control. Means ± SE, n = 6 (LC3), n = 3 (p62). (F) Proteasome activity in head extracts of 30-day-old control and <italic>milton</italic> knockdown flies. Means ± SE, n = 3. <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05; *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.005 (Student’s <italic>t</italic>-test).</p></caption>
<graphic xlink:href="576435v4_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>At 30-day-old, LC3-I was still higher, and the LC3-II/LC3-I ratio was lower, in <italic>milton</italic> knockdown compared to the control (<xref rid="fig2" ref-type="fig">Figure 2D</xref>). At this age, <italic>milton</italic> knockdown increased p62 significantly in 1% Triton X-100 fraction and 2% SDS fraction (<xref rid="fig2" ref-type="fig">Figure 2E</xref>). Proteasome activities were also decreased in <italic>milton</italic> knockdown flies at 30-day-old (<xref rid="fig2" ref-type="fig">Figure 2F</xref>). These results indicate that depletion of axonal mitochondria impairs protein degradation pathways.</p>
</sec>
<sec id="s2c">
<title>ATP deprivation does not impair autophagy</title>
<p><italic>milton</italic> knockdown downregulates ATP in the axon<sup><xref ref-type="bibr" rid="c33">33</xref></sup>. To examine whether the disruption of protein degradation pathways by <italic>milton</italic> knockdown is due to ATP deprivation, we investigated the effects of knocking down phosphofructokinase (<italic>Pfk</italic>), a rate-limiting enzyme in glycolysis, on protein degradation pathways. Neuronal knockdown of <italic>Pfk</italic> was reported to lower ATP levels in brain neurons<sup><xref ref-type="bibr" rid="c33">33</xref></sup>. <italic>Pfk</italic> knockdown and <italic>milton</italic> knockdown decreased ATP to similar levels (<xref rid="fig3" ref-type="fig">Figure 3A-C</xref>). However, in contrast with <italic>milton</italic> knockdown, <italic>Pfk</italic> knockdown did not affect the levels of LC3-I, LC3-II or the LC3-II/LC3-I ratio (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). <italic>Pfk</italic> knockdown decreased p62 level (<xref rid="fig3" ref-type="fig">Figure 3E</xref>), suggesting that autophagy is promoted. On the other hand, proteasome activity was decreased by <italic>Pfk</italic> knockdown (<xref rid="fig3" ref-type="fig">Figure 3F</xref>). These results suggest that the downregulation of axonal ATP upon depletion of axonal mitochondria decreases proteasome activity, but not autophagy.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>ATP deprivation does not impair autophagy</title>
<p>(A-C) ATP levels in brain extracts of control and <italic>milton</italic> knockdown flies (A) and control and <italic>Pfk</italic> knockdown flies (B) and comparison of the effects of <italic>milton</italic> knockdown and <italic>Pfk</italic> knockdown on ATP levels (C). Flies were 14-day-old. Means ± SE, n = 3. (D, E) Western blotting of head extracts of flies with neuronal expression of control or <italic>Pfk</italic> RNAi. Blotting was performed with anti-LC3 (D) and anti-p62 (E) antibodies. For analyses of p62 levels, heads were extracted with 1% Triton X-100 or 2% SDS. Representative blots (left) and quantitation (right) are shown. Actin was used as a loading control. Means ± SE, n = 6 (LC3), n = 3 (p62). (F) Proteasome activity in head lysates of flies with neuronal expression of control or <italic>Pfk</italic> RNAi was measured by hydrolysis of Suc-LLVY-AMC. Means ± SE, n = 3. <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05; *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.005 (Student’s <italic>t</italic>-test). Flies were at 14-day-old.</p></caption>
<graphic xlink:href="576435v4_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>Proteome analysis suggests that depletion of axonal mitochondria causes disruption of autophagy and premature aging</title>
<p>To identify the pathways that mediate the decrease in autophagy in <italic>milton</italic> knockdown brains, we performed proteome analysis to systematically detect differentially expressed proteins upon neuronal knockdown of <italic>milton</italic>. We analyzed flies at 7- and 21-day-old, the age before autophagic defects are detected and the age just before the onset of neurodegeneration, respectively (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). 1039 proteins were detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Expression of 36 proteins was significantly increased (22 proteins) or decreased (14 proteins) by <italic>milton</italic> knockdown at 7-day-old (<xref rid="fig4" ref-type="fig">Figure 4B</xref>, Tables 1 and S1). At 21-day-old, the expression of 41 proteins (31 upregulated and ten downregulated proteins) was significantly altered in <italic>milton</italic> knockdown flies compared with control flies (<xref rid="fig4" ref-type="fig">Figure 4C</xref>, Tables 1 and S1). The “Interaction search” algorithm using KeyMolnet showed that proteins whose expression was significantly altered in the brains of <italic>milton</italic> knockdown flies at both 7- and 21-day-old were closely associated with the autophagic pathway (Table 2). Proteins involved in pathways characteristics of aging, such as the immune response (Transcriptional regulation by STAT), cancer (Transcriptional regulation by SMAD, Transcriptional regulation by myc), longevity (Transcriptional regulation by FOXO, Sirtuin signaling pathway), and stress responses (HSP90 signaling pathway, MAPK signaling pathway)<sup><xref ref-type="bibr" rid="c34">34</xref>,<xref ref-type="bibr" rid="c35">35</xref></sup>, were enriched in the proteome profiles of <italic>milton</italic> knockdown flies compared with those of control flies at 7-day-old (Table 2), suggesting that depletion of axonal mitochondria accelerates aging in the brain.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title><italic>milton</italic> knockdown upregulates eIF2β in young flies</title><p>(A) Timing of proteome analysis and phenotypes observed in <italic>milton</italic> knockdown flies. (B, C) Scatter plots of the log<sub>2</sub> abundance ratio (x-axis) against the -log<sub>10</sub> p-value (y-axis) of proteins at 7-day-old (B) and 21-day-old (C). (D) eIF2 subunit protein levels from proteome analysis of <italic>milton</italic> knockdown flies compared to those of control flies. (E) Western blotting of head extracts of flies expressing control or <italic>milton</italic> RNAi in neurons with an anti-eIF2β antibody. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n = 6. (F) <italic>eIF2</italic>β mRNA levels quantified by qRT-PCR. Means ± SE, n = 4. (G) Western blotting of head extracts of wild-type flies with an anti-eIF2β antibody. Flies were 7-, 21-, 35-, 49- and 63-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n = 3, *<italic>p</italic> &lt; 0.05 (one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test).</p></caption>
<graphic xlink:href="576435v4_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2e">
<title>Depletion of axonal mitochondria upregulates eIF2<bold>β</bold> and decreases phosphorylation of eIF2<bold>α</bold></title>
<p>Differentially expressed proteins at 7-day-old flies may reflect alterations that are causal for autophagic defects. We noticed that the expression level of eIF2β was 2.465-fold higher in the brains of <italic>milton</italic> knockdown flies than in those of control flies (<xref rid="fig4" ref-type="fig">Figure 4B and D</xref>). Upregulation of eIF2β in the brains of <italic>milton</italic> knockdown flies was confirmed by western blotting. <italic>milton</italic> knockdown increased eIF2β protein levels more than twice (<xref rid="fig4" ref-type="fig">Figure 4E</xref>), but did not change the level of <italic>eIF2</italic>β mRNA (<xref rid="fig4" ref-type="fig">Figure 4F</xref>).</p>
<p>We also investigated age-dependent changes in eIF2β by western blotting of control flies at 7-, 21-, 35-, and 49-, and 63-day-old. eIF2β levels increased during aging until 49-day-old (<xref rid="fig4" ref-type="fig">Figure 4G</xref>). These results suggest that upregulation of eIF2β in <italic>milton</italic> knockdown fly brain reflects early an onset of age-dependent increase of eIF2β levels. eIF2β is a subunit of the eukaryotic initiation factor 2 (eIF2) complex, which is critical for translation initiation and the integrated stress response (ISR)<sup><xref ref-type="bibr" rid="c4">4</xref></sup>. eIF2 is a heterotrimer of α, β, and γ subunits, and eIF2α is phosphorylated during the ISR<sup><xref ref-type="bibr" rid="c6">6</xref></sup>. As for the other subunits of eIF2 complex, proteome analysis did not detect a significant difference in the protein levels of eIF2α and eIF2γ between <italic>milton</italic> knockdown and control flies at 7- and 21-day-old (<xref rid="fig4" ref-type="fig">Figure 4D</xref>). Western blotting of brain lysates showed that <italic>milton</italic> knockdown reduced eIF2α levels (<xref rid="fig5" ref-type="fig">Figure 5A</xref>), while p-eIF2α levels were not significantly affected (<xref rid="fig5" ref-type="fig">Figure 5B</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title><italic>milton</italic> knockdown decreases phosphorylation of eIF2α</title><p>(A, B) Western blotting of head extracts with anti-eIF2α (A) and anti-p-eIF2α (B) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n = 6. (C) A schematic representation of the axon (Lobe tips), the cell body region (Kenyon cells), and dendritic region (Calyxes) in the fly brain. Scale bars, 100µm. (D, E) Immunostaining with anti-eIF2α and anti-p-eIF2α antibodies. The mushroom body was identified by expression of mito-GFP. Scale bars, 20µm. The signal intensities of eIF2α and p-eIF2α in axons, dendrites, and cell bodies were quantified and are shown as ratios relative to the control. Means ± SE, nC=12. <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05; *<italic>p</italic> &lt; 0.05; **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.005 (Student’s <italic>t</italic>-test).</p></caption>
<graphic xlink:href="576435v4_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To analyze local changes of eIF2α and p-eIF2α, we carried out immunostaining. We focused on the mushroom body, where axons, dendrites, and cell bodies can be easily identified (<xref rid="fig5" ref-type="fig">Figure 5C</xref>). Both eIF2α and p-eIF2α were downregulated in the cell body (Kenyon cells) and dendritic (Calyxes) regions of the brains of <italic>milton</italic> knockdown flies (<xref rid="fig5" ref-type="fig">Figure 5D</xref>). In axons (lobe tips), <italic>milton</italic> knockdown did not affect eIF2α (<xref rid="fig5" ref-type="fig">Figure 5E</xref>, <italic>p</italic> = 0.271) but significantly downregulated p-eIF2α (<xref rid="fig5" ref-type="fig">Figure 5E</xref>). The ratio of p-eIF2α to eIF2α was lower in the axon but not in the soma or dendritic region. These results suggest that axonal distribution of mitochondria regulate the level of overall eIF2α protein and local p-eIF2α.</p>
</sec>
<sec id="s2f">
<title>Depletion of axonal mitochondria suppressed global translation</title>
<p>Phosphorylation of eIF2α induces conformational changes in the eIF2 complex and inhibits global translation<sup><xref ref-type="bibr" rid="c36">36</xref></sup>. To analyze the effects of <italic>milton</italic> knockdown on translation, we performed polysome gradient centrifugation to examine the level of ribosome binding to mRNA. Since p-eIF2α was downregulated, we hypothesized that <italic>milton</italic> knockdown would enhance translation. However, unexpectedly, we found that <italic>milton</italic> knockdown significantly reduced the level of mRNAs associated with polysomes (<xref rid="fig6" ref-type="fig">Figure 6A and B</xref>). We also compared the level of translation between the brains of control and <italic>milton</italic> knockdown flies by assessing the incorporation of puromycin (<xref rid="fig6" ref-type="fig">Figure 6C</xref>). Puromycin incorporation was lower in the brains of <italic>milton</italic> knockdown flies than in those of control flies, while it was not statistically significant (<xref rid="fig6" ref-type="fig">Figure 6C</xref>, indicated by a bracket). These data suggest that the depletion of axonal mitochondria suppresses global translation.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title><italic>milton</italic> knockdown suppressed global translation</title><p>(A) Representative polysome traces of head lysates of control and <italic>milton</italic> knockdown flies. (B) Quantitation of polysome fraction. The relative ratio of area under the curve (AUC) of polysome fractions (sedimentation 28%-50%). Means ± SE, n = 3. ***<italic>p</italic> &lt; 0.005 (Student’s <italic>t</italic>-test) (C) Western blotting of head lysates of control and <italic>milton</italic> knockdown flies fed puromycin alone or puromycin and cycloheximide (CHX) with an anti-puromycin antibody. Flies were 14-day-old. Actin was used as a loading control. Representative blots (left) and quantitation (right) are shown. Means ± SE, n = 3. Student’s <italic>t</italic>-test.</p></caption>
<graphic xlink:href="576435v4_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2g">
<title>eIF2<bold>β</bold> upregulation reduces the level of p-eIF2<bold>α</bold>, impairs autophagy, and decreases locomotor function</title>
<p>We were motivated to ask if eIF2β upregulation mediates autophagic defects caused by <italic>milton</italic> knockdown. If so, neuronal overexpression of <italic>eIF2</italic>β would also induce autophagy impairment. Neuronal overexpression of <italic>eIF2</italic>β increased LC3-II, while the LC3-II/LC3-I ratio was not significantly different (<xref rid="fig7" ref-type="fig">Figure 7A and B</xref>). Overexpression of <italic>eIF2</italic>β significantly increased the p62 level in the Triton X-100-soluble fraction (<xref rid="fig7" ref-type="fig">Figure 7C</xref>, 4-fold vs. control, <italic>p</italic> &lt; 0.005 (1% Triton X-100)) but not in the SDS-soluble fraction (<xref rid="fig7" ref-type="fig">Figure 7C</xref>, 2-fold vs. control, <italic>p</italic> = 0.062 (2% SDS)), as observed in brains of <italic>milton</italic> knockdown flies (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). These data suggest that neuronal overexpression of <italic>eIF2</italic>β accumulates autophagic substrates.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>eIF2β upregulation impairs autophagy and decreases locomotor function</title>
<p>(A) <italic>eIF2</italic>β mRNA levels in head extracts of flies with UAS-<italic>eIF2</italic>β driven by elav-Gal4 (<italic>eIF2</italic>β OE) or UAS-GFP driven by elav-Gal4 (control) were quantified by qRT-PCR. Flies were 2-day-old. Means ± SE, n=4. (B, C) Western blotting of head extracts with anti-LC3 (B) and anti-p62 (C) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin and actin were used as loading controls. Means ± SE, n = 3 (p62), n = 5 (LC3). (D, E) Western blotting of head extracts with anti-eIF2α (D) and anti-p-eIF2α (E) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n = 6. (F) Climbing assay revealed early-onset of age-dependent locomotor defects in <italic>eIF2</italic>β-overexpressing flies. Means ± SE, n = 5. <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05; ***<italic>p</italic> &lt; 0.005 (Student’s <italic>t</italic>-test).</p></caption>
<graphic xlink:href="576435v4_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Since <italic>milton</italic> knockdown reduced the p-eIF2α level (<xref rid="fig5" ref-type="fig">Figure 5E</xref>), we asked whether an increase in eIF2β affects p-eIF2α. Neuronal overexpression of <italic>eIF2</italic>β did not affect the eIF2α level but significantly decreased the p-eIF2α level (<xref rid="fig7" ref-type="fig">Figure 7D and E</xref>).</p>
<p>Depletion of axonal mitochondria causes age-dependent decline in locomotor function<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. We found that neuronal overexpression of <italic>eIF2</italic>β also caused locomotor dysfunction (<xref rid="fig7" ref-type="fig">Figure 7F</xref>). Locomotor functions were significantly impaired in those flies at 20-day-old and worsened further during aging (<xref rid="fig7" ref-type="fig">Figure 7F</xref>, compare 4-, 20-, and 30-day-old). We asked if <italic>eIF2</italic>β overexpression causes neurodegeneration, as depletion of axonal mitochondria in the photoreceptor neurons causes axon degeneration in an age-dependent manner<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. <italic>eIF2</italic>β overexpression in photoreceptor neurons tends to increase neurodegeneration in aged flies, while it was not statistically significant (p&gt;0.05, Figure S2).</p>
<p>These data indicate that an increase of eIF2β in neurons phenocopies depletion of axonal mitochondria, including suppression of autophagy and age-dependent locomotor dysfunction, and suggest that increase of eIF2β mediates these phenotypes downstream of loss of axonal mitochondria.</p>
</sec>
<sec id="s2h">
<title>Lowering <italic>eIF2</italic><bold>β</bold> rescues autophagic impairment and locomotor dysfunction induced by <italic>milton</italic> knockdown</title>
<p>Finally, we investigated whether suppression of eIF2β rescues autophagy impairment and locomotor dysfunction caused by neuronal knockdown of <italic>milton</italic>. Null mutants and flies with RNAi-mediated knockdown of <italic>eIF2</italic>β in neurons did not survive. Flies lacking one copy of the <italic>eIF2</italic>β gene survived without any gross abnormality, and the level of <italic>eIF2</italic>β mRNA in these flies was about 80% of that in control flies (<xref rid="fig8" ref-type="fig">Figure 8A</xref>). <italic>eIF2</italic>β heterozygosity did not affect the eIF2α and p-eIF2α levels (Figure S3A and B).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Lowering <italic>eIF2</italic>β rescues autophagic impairment and locomotor dysfunction induced by <italic>milton</italic> knockdown</title>
<p>(A) <italic>eIF2</italic>β mRNA levels with one disrupted copy of the <italic>eIF2</italic>β gene (<italic>eIF2</italic>βSAstopDsRed/+ (<italic>eIF2</italic>β -/+)). Head extracts of flies 2-3 day-old were analyzed by qRT-PCR. Means ± SE, n = 3. (B, C) Western blotting of head extracts of flies with neuronal expression of <italic>milton</italic> RNAi with or without <italic>eIF2</italic>β heterozygosity with anti-LC3 (B) and anti-p62 (C) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Actin was used as a loading control. Means ± SE, n = 5 (LC3), n = 3 (p62). (D) The climbing ability of 20-day-old flies expressing <italic>milton</italic> RNAi with or without <italic>eIF2</italic>β heterozygosity. Means ± SE, n = 15. <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05; *<italic>p</italic> &lt; 0.05; ***<italic>p</italic> &lt; 0.005 (Student’s <italic>t</italic>-test).</p></caption>
<graphic xlink:href="576435v4_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Neuronal knockdown of <italic>milton</italic> causes accumulation of autophagic substrate p62 in the Triton X-100-soluble fraction (<xref rid="fig2" ref-type="fig">Figure 2B</xref>), and we tested if lowering eIF2β ameliorates it. We found that <italic>eIF2</italic>β heterozygosity caused a mild increase in LC3-I levels and decreases in LC3-II levels, resulting in a significantly lower LC3-II/LC3-I ratio in <italic>milton</italic> knockdown flies (<xref rid="fig8" ref-type="fig">Figure 8B</xref>). <italic>eIF2</italic>β heterozygosity decreased the p62 level in the Triton X-100-soluble fraction in the brains of <italic>milton</italic> knockdown flies (<xref rid="fig8" ref-type="fig">Figure 8C</xref>). The p62 level in the SDS-soluble fraction, which is not sensitive to <italic>milton</italic> knockdown (<xref rid="fig2" ref-type="fig">Figure 2B</xref>), was not affected (<xref rid="fig8" ref-type="fig">Figure 8C</xref>). These results suggest that suppression of <italic>eIF2</italic>β ameliorates the impairment of autophagy caused by <italic>milton</italic> knockdown.</p>
<p><italic>eIF2</italic>β heterozygosity also rescued locomotor dysfunction induced by <italic>milton</italic> knockdown. <italic>milton</italic> knockdown flies with <italic>eIF2</italic>β heterozygosity exhibited better locomotor function than <italic>milton</italic> knockdown alone (<xref rid="fig8" ref-type="fig">Figure 8D</xref>). The <italic>milton</italic> mRNA level was not increased in these flies, indicating that the rescue effect in the <italic>eIF2</italic>β heterozygous background was not mediated by an increase in the <italic>milton</italic> mRNA level (Figure S3C). These data suggest that eIF2β upregulation mediates autophagy impairment and locomotor dysfunction caused by the depletion of axonal mitochondria.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>The depletion of axonal mitochondria and accumulation of abnormal proteins are both characteristics of aged brains<sup><xref ref-type="bibr" rid="c37">37</xref>,<xref ref-type="bibr" rid="c38">38</xref></sup>. Proteostasis perturbations trigger the formation of pathological aggregates and increase the risks of neurodegenerative diseases during aging. By using neuronal <italic>milton</italic> knockdown to deplete mitochondria from the axon, we provide evidence that loss of axonal mitochondria drives age-related proteostasis collapse via eIF2β (<xref rid="fig9" ref-type="fig">Figure 9</xref>). We observed declines in autophagy-mediated degradation of less-aggregated proteins and proteasome activity in <italic>milton</italic> knockdown flies (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Accumulation of ubiquitinated proteins and changes in age-related pathways started prematurely in <italic>milton</italic> knockdown flies (<xref rid="fig1" ref-type="fig">Figure 1</xref> and Table 2). <italic>milton</italic> knockdown increased eIF2β and lowered eIF2α phosphorylation in young fly brain (<xref rid="fig4" ref-type="fig">Figure 4</xref> and <xref rid="fig5" ref-type="fig">5</xref>). Overexpression of <italic>eIF2</italic>β phenocopied the effects of <italic>milton</italic> knockdown, including reduced autophagy and accelerated age-related locomotor defects (<xref rid="fig7" ref-type="fig">Figure 7</xref>). Furthermore, lowering <italic>eIF2</italic>β levels suppressed the impairment of autophagy and locomotor dysfunction induced by <italic>milton</italic> knockdown (<xref rid="fig8" ref-type="fig">Figure 8</xref>). From these results, we propose that upregulation of eIF2β downstream of depletion of axonal mitochondria drives age-dependent collapse of proteostasis (<xref rid="fig9" ref-type="fig">Figure 9</xref>). Our results suggest that mitochondrial distribution and eIF2β are part of the mechanisms constituting proteostasis.</p>
<fig id="fig9" position="float" orientation="portrait" fig-type="figure">
<label>Figure 9.</label>
<caption><title>Graphical abstract: the mitochondria-eIF2β axis in the axon maintains neuronal proteostasis during aging</title></caption>
<graphic xlink:href="576435v4_fig9.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p><italic>milton</italic> knockdown causes loss of mitochondria in the axon and accumulation of mitochondria in the soma. Thus, the detrimental effects may be mediated by the accumulation of mitochondria. However, degeneration induced by <italic>milton</italic> knockdown is prominent in the axon and not detected in the cell body<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. Furthermore, abnormal protein accumulation was observed in the axon (<xref rid="fig1" ref-type="fig">Figure 1</xref>), and p-eIF2α/eIF2α was decreased in the neurites but not in the soma (<xref rid="fig5" ref-type="fig">Figure 5</xref>), suggesting that proteostasis defects studied in this work are caused by depletion of mitochondria rather than accumulation of mitochondria. Further analyses to dissect the effects of <italic>milton</italic> knockdown on proteostasis and translation in the cell body and axon by experiments with spatial resolution would be needed.</p>
<p>Our results suggest that the loss of axonal mitochondria is an event upstream of proteostasis collapse during aging. The number of puncta of ubiquitinated proteins was higher in milton knockdown at 14-day-old, but there was no significant difference at 30-day-old (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Proteome analyses also showed that age-related pathways, such as immune responses, are enhanced in young flies with <italic>milton</italic> knockdown (Table 2). We also found that eIF2β protein levels increase in an age-dependent manner until 49-day-old and reduces after that (<xref rid="fig4" ref-type="fig">Figure 4G</xref>). In the brains with neuronal knockdown of <italic>milton</italic>, eIF2β levels were higher at 7-day-old than those in control and lower at the 21-day-old (<xref rid="fig4" ref-type="fig">Figure 4D</xref> and Supplementary table). These results suggest that <italic>milton</italic> knockdown is likely accelerating age-dependent changes rather than increasing their magnitude. Disruption of proteostasis is expected to contribute neurodegeneration<sup><xref ref-type="bibr" rid="c38">38</xref></sup>, and it would be interesting to analyze the sequence of protein accumulation and axonal degeneration in <italic>milton</italic> knockdown (<sup><xref ref-type="bibr" rid="c24">24</xref>,<xref ref-type="bibr" rid="c29">29</xref></sup> and <xref rid="fig1" ref-type="fig">Figure 1</xref>) in detail with higher time resolution.</p>
<p>Our results revealed that eIF2β regulates autophagy and maintains proteostasis during aging. eIF2β is a component of eIF2, which meditates translational regulation and ISR initiation. When ISR is activated, phosphorylated eIF2α suppresses global translation and induces translation of ATF4, which mediates transcription of autophagy-related genes<sup><xref ref-type="bibr" rid="c39">39</xref>,<xref ref-type="bibr" rid="c40">40</xref></sup>. Since ISR can positively regulate autophagy, we suspected that suppression of ISR underlies a reduction in autophagic protein degradation. We found neuronal knockdown of <italic>milton</italic> reduced phosphorylated eIF2α, suggesting that ISR is reduced (<xref rid="fig5" ref-type="fig">Figure 5</xref>). However, we also found that global translation was reduced (<xref rid="fig6" ref-type="fig">Figure 6</xref>). Increased levels of eIF2β might disrupt the eIF2 complex or alter its functions. The stoichiometric mismatch caused by an imbalance of eIF2 components may inhibit ISR induction. Supporting this model, we found that eIF2β upregulation reduced the levels of p-eIF2α (<xref rid="fig7" ref-type="fig">Figure 7</xref>). It is also possible that eIF2β mediates autophagy defects via mechanisms independent of ISR since eIF2β has functions independent of eIF2<sup><xref ref-type="bibr" rid="c41">41</xref>,<xref ref-type="bibr" rid="c42">42</xref></sup>. For example, suppression of <italic>eIF2</italic>β has been reported to slow down cancer cell growth<sup><xref ref-type="bibr" rid="c41">41</xref></sup>. In developing neurons, eIF2β can directly interact with the translational repressor Kra to regulate midline axon guidance<sup><xref ref-type="bibr" rid="c42">42</xref></sup>. Our results also suggest that milton knockdown and overexpression of eIF2β affect autophagy via increased LC3-I abundance (<xref rid="fig2" ref-type="fig">Figures 2</xref> and <xref rid="fig7" ref-type="fig">7</xref>), suggesting an unconventional mechanism of autophagy suppression. To our knowledge, the roles of eIF2β in aging and autophagy independent of ISR have not been reported. Our results revealed a novel function of eIF2β to maintain proteostasis during aging, while further investigation is required to elucidate underlying mechanisms.</p>
<p>How depletion of axonal mitochondria upregulates eIF2β is currently under investigation. A major mitochondrial function is ATP production, and depletion of axonal mitochondria downregulates ATP in axons<sup><xref ref-type="bibr" rid="c33">33</xref></sup>. However, we found that ATP deprivation did not always suppress autophagy (<xref rid="fig3" ref-type="fig">Figure 3</xref>), suggesting it is unlikely to be involved in the mechanisms that induce eIF2β upregulation. Mitochondria also serve as signaling hubs for translation and protein degradation. Mitochondrial proteins are regulated by co-translational protein quality control, and mitochondrial damage induces translational stalling of mitochondrial outer membrane-associated <italic>complex-I 30 kD subunit</italic> (<italic>C-I30</italic>) mRNA<sup><xref ref-type="bibr" rid="c43">43</xref></sup>. Additionally, the mitochondrial outer membrane ubiquitin ligase MITOL (also known as MARCHF5) ubiquitinates and regulates not only mitochondrial proteins such as Mfn2<sup><xref ref-type="bibr" rid="c44">44</xref></sup> but also microtubule-associated<sup><xref ref-type="bibr" rid="c45">45</xref></sup> and endoplasmic reticulum<sup><xref ref-type="bibr" rid="c46">46</xref></sup> proteins. These findings indicate that mitochondria serve as local signaling centers for proteostasis maintenance, and eIF2β levels may also be regulated by mechanisms related to mitochondria.</p>
<p>In conclusion, our results suggest that axonal mitochondria and eIF2β form an axis to maintain constitutive autophagy. Suppression of <italic>eIF2</italic>β rescued autophagic defects and neuronal dysfunction upon loss of axonal mitochondria. Since eIF2β is conserved across many species, including <italic>Drosophila</italic> and humans, our results suggest that eIF2β may be a possible therapeutic target for aging and diseases associated with mitochondrial mislocalization.</p>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Fly stocks and husbandry</title>
<p>Flies were maintained in standard cornmeal medium (10% glucose, 0.7% agar, 9% cornmeal, 4% yeast extract, 0.3% propionic acid, and 0.1% n-butyl p-hydroxybenzoate) at 25°C under light–dark cycles of 12:12 h. The flies were transferred to fresh food vials for every 2–3 days. UAS-<italic>milton</italic> RNAi (v41508) was from VDRC and outcrossed to [w1118] for five generations in our laboratory. Transgenic fly lines carrying UAS-<italic>luciferase</italic> RNAi control for <italic>milton</italic> RNAi) was reported previously<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. GMR-gal4, Elav-gal4, UAS-<italic>Pfk</italic> RNAi (Bloomington stock center #36782), UAS-<italic>luciferase</italic> RNAi (Bloomington stock center #31603) (control for <italic>Pfk</italic> RNAi), UAS-<italic>GFP</italic> (used for control for UAS-<italic>eIF2</italic>β) and UAS-<italic>eIF2</italic>β (eIF2β<sup>EY08063</sup>, Bloomington stock center #17425) were from the Bloomington stock center. <italic>eIF2</italic>β heterozygous strain (PBac{SAstopDsRed} LL07719, DGRC#142114) was from KYOTO <italic>Drosophila</italic> Stock Center. UAS-<italic>mitoGFP</italic> was a kind gift from Drs. W. M. Saxton (University of California, Santa Cruz).</p>
</sec>
<sec id="s4b">
<title>Immunohistochemistry and image acquisition</title>
<p>Fly brains were dissected in PBS and fixed for 45 minutes in formaldehyde (4% v/v in PBS) at room temperature. After incubation in PBST containing 0.1% Triton X-100 for 10 min three times, samples were incubated for 1h at room temperature in PBST containing 1% normal goat serum (Wako, #143-06561) and then incubated overnight with the primary antibody (anti-ubiquitin antibody Ubi-1 (Thermo Fisher #13-1600) (1:50), anti-eIF2α (abcam #ab26197) (1:50) and anti-p-eIF2α (Cell signaling #3398S) (1:50)) diluted in 1% NGS/PBST at 4 °C. Samples were then washed for 10 min with PBST including 0.1% Triton X-100 three times and incubated with the secondary antibody for overnight at 4° C. Brains were mounted in Vectashield (Vectorlab Cat#H-1100) and analyzed under a confocal microscope (Nikon). Quantitative analysis was performed using ImageJ (National Institutes of Health) with maximum projection images derived from Z-stack images acquired with same settings. Puncta were identified with mean intensity and area using ImageJ. For eIF2α and p- eIF2α immunostaining, the mushroom body was detected by mitoGFP expression.</p>
</sec>
<sec id="s4c">
<title>Electron microscopy</title>
<p>Proboscis was removed from decapitated heads, which were then incubated in primary fixative solution (2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer) at R.T. for 2 hours. After washing heads with 3% sucrose in 0.1 M sodium cacodylate buffer, fly heads were post-fixed for 1 hour in secondary fixation (1% osmium tetroxide in 0.1 M sodium cacodylate buffer) on ice. After washing with H<sub>2</sub>O, heads were dehydrated with ethanol and infiltrated with propylene oxide and Epon mixture (TAAB and Nissin EM) for 3 hours. After infiltration, specimens were embedded with an Epon mixture at 70°C for 2-3 days. Thin sections (70 nm) of laminas were collected on copper grids. The sections were stained with 5% uranyl acetate in 50% ethanol and Reynolds’ lead citrate solution. Electron micrographs were obtained with a CCD Camera mounted on a JEM-1400 plus electron microscope (Jeol Ltd.). Quantitation was performed using ImageJ (National Institutes of Health).</p>
</sec>
<sec id="s4d">
<title>SDS–PAGE and immunoblotting</title>
<p>Western blotting was performed as reported previously<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. Briefly, heads of 10-20 <italic>Drosophila</italic> were homogenized with SDS-Tris-Glycine sample buffer (0.312M Tris, 5% SDS, 8% glycerol, 0.0625% BPB, 10% β-mercaptoethanol, 10μg/mL leupeptin, 0.4 μM Pefabloc, 10mM β-glycerphosphate, 10mM NaF) and after boiling at 95°C for 2 minutes, it was centrifuged at 13,200 rpm, and the supernatant was used as a sample. For p62 western blot, fly heads were homogenized with 1% PBST and after centrifugation at 13,200 rpm, the supernatant was mixed 1:1 SDS-Tris-Glycine sample buffer, and boiled at 95 °C for 2 minutes. The pellet was dissolved with 2% SDS in PBS, then centrifuged again at 13,200 rpm. The supernatant was mixed 1:1 SDS-Tris-Glycine sample buffer and then boiled at 95 °C for 2 minutes. SDS–PAGE for western blotting was performed using 15%(w/v) (LC3), 7.5%(w/v) (p62), 10% (w/v) (eIF2α, β, and p-eIF2α) polyacrylamide gels. After electrophoresis, they were transferred to PVDF membrane (Merck Millipore) using a transfer device (BIO-RAD). After transfer, the membrane was blocked with 5% skim milk/TBST (50 mM Tris (pH 7.5), 0.15 M NaCl, 0.05% Tween20) for 1 hour and incubated with primary antibody listed below overnight at 4 °C. Membranes were rinsed twice with TBST containing 0.65M NaCl and once with TBST containing 0.15M NaCl. After incubation with the secondary antibody at room temperature for 1 hour, membranes were rinsed twice with TBST containing 0.65M NaCl and once with TBST containing 0.15M NaCl. After incubation with Immobilon Western Chemiluminescent HRP Substrate (Merck Millipore), chemiluminescent signals were detected with Fusion FX (Vilber). Experiments were repeated at least 3 times with independent cohorts of flies.</p>
<p>Primary antibodies: anti-LC3 antibody Atg8 (Merck Millipore #ABC975) (1:1000), anti-p62 antibody Ref2P (abcam #ab178440) (1:750), anti-eIF2β antibody (1:1500), anti-eIF2α antibody (abcam #ab26197) (1:1000), anti-p-eIF2α antibody (Cell signaling #3398S) (1:2000), anti-actin antibody (SIGMA A2066) (1:3000) and anti-β tubulin antibody (Sigma #T9026) (1:800,000). Polyclonal anti-eIF2β antibody was raised against a synthetic peptide (CGLEDDTKKEDPQDEA) corresponding to the C-terminal residues 29-43 of <italic>Drosophila</italic> eIF2β (1:1500).</p>
<p>Secondary antibodies: Peroxidase-conjugated goat anti-mouse IgG antibody (Dako #P0447) (1:2000), peroxidase-conjugated pig anti-rabbit IgG antibody (Dako #P0399) (1:2000)</p>
</sec>
<sec id="s4e">
<title>Proteasome assay</title>
<p>Heads from ten flies were homogenized in 150 µl of buffer B (25 mM Tris-HCl [pH 7.5], 2 mM ATP, 5 mM MgCl2, and 1 mM dithiothreitol). Proteasome peptidase activity in the lysates was measured with a synthetic peptide substrate, succinyl-Leu-Leu-Val-Tyr-7-amino-4-methyl-coumarin (Suc-LLVY-AMC) (Cayman). Luminescence was measured on a multimode plate reader 2300 Enspire (PerkinElmer). Experiments were repeated at least 3 times with independent cohorts of flies.</p>
</sec>
<sec id="s4f">
<title>ATP assay</title>
<p>Heads from the 10 flies were homogenized in 50Cμl of 6CM guanidine-HCl in extraction buffer (100CmM Tris and 4CmM EDTA, pH 7.8) to inhibit ATPases. Samples were boiled for 5Cmin and centrifuged. The supernatant was diluted 4% with extraction buffer and mixed with a reaction solution (ATP Determination kit, Invitrogen). Luminescence was measured on a multimode plate reader 2300 Enspire (PerkinElmer). The relative ATP levels were calculated by dividing the luminescence by the total protein concentration, which was determined by the Bradford method. Experiments were repeated at least 3 times with independent cohorts of flies.</p>
</sec>
<sec id="s4g">
<title>Proteomic assay and pathway analysis</title>
<sec id="s4g1">
<title>Sample preparation</title>
<p>Heads from the 35 flies were homogenized in 110 µl of extraction buffer (0.25% RapiGest SF, 50mM ammonium bicarbonate, 10mM dithiothreitol, 10μg/mL leupeptin, 0.4 μM Pefabloc, 10mM β-glycerphosphate, 10mM NaF). Homogenized samples were centrifuged and boiled for 5Cmin. After quantification of the protein concentration using a Pierce® 660 nm Protein Assay (Thermo Fisher Scientific), 10 µg proteins from each sample were reduced using 5 mM tris (2-carboxyethyl) phosphine hydrochloride (TCEP-HCl; Thermo Fisher Scientific) at 60°C for 1 h, alkylated using 15 mM iodoacetamide (Fujifilm Wako Pure Chemical, Osaka, Japan) at room temperature for 30 min, and then digested using 1.5 µg Trypsin Gold (Mass Spectrometry Grade; Promega, Madison, WI, USA) at 37°C for 17 h. The digests were acidified by the addition of trifluoroacetic acid (TFA), incubated at 37°C for 30 min, and then centrifuged at 17,000 ×<italic>g</italic> for 10 min to remove the RapiGest SF. The supernatants were collected and desalted using MonoSpin™ C18 (GL Sciences, Tokyo, Japan). The resulting eluates were concentrated <italic>in vacuo</italic>, dissolved in 2% MeCN containing 0.1% formic acid (FA), and subjected to LC-MS/MS analysis.</p>
</sec>
<sec id="s4g2">
<title>LC-MS/MS analysis and database search</title>
<p>LC-MS/MS analyses were performed on an Ultimate 3000 RSLCnano system (Thermo Fisher Scientific) coupled to a Q Exactive hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific) equipped with a nano electron spray ionization (ESI) source. The LC system was equipped with a trap column (C18 PepMap 100, 0.3 × 5 mm, 5 µm, Thermo Fisher Scientific) and an analytical column (NTCC-360/75-3-125, Nikkyo Technos, Tokyo, Japan). Peptide separation was performed using a 90-min gradient of water/0.1% FA (mobile phase A) and MeCN/0.1% FA (mobile phase B) at a flow rate of 300 nL/min. Elution was performed as follows: 0–3 min, 2% B; 3–93 min, 2%–40% B; 93–95 min, 40%–95% B; 95–105 min, 95% B; 105–107 min, 95%–2% B; and 107–120 min, 2% B. The mass spectrometer was operated in data-dependent acquisition mode. The MS parameters were as follows: spray voltage, 2.0 kV; capillary temperature, 275°C; S-lens RF level, 50; scan type, full MS; scan range, <italic>m/z</italic> 350–1500; resolution, 70,000; polarity, positive; automatic gain control target, 3 × 10<sup>6</sup>; and maximum injection time, 100 msec. The MS/MS parameters were as follows: resolution, 17,500; automatic gain control target, 1 × 10<sup>5</sup>; maximum injection time, 60 msec; normalized collision energy (NCE), 27; dynamic exclusion, 15 sec; loop count, 10; isolation window, 1.6 <italic>m/z</italic>; charge exclusion: unassigned, 1 and ≥8; and injection volume, 1 µL (containing 0.5 µg protein). Measurements were made in duplicate for each sample.</p>
<p>The identification of proteins and label-free quantification (LFQ) of the detected peptides were performed using Proteome Discoverer software ver. 2.4 (Thermo Fisher Scientific). The analytical parameters used for the database search were as follows: parent mass error tolerance, 10.0 ppm; fragment mass error tolerance, 0.02 Da; search engine, sequest HT; protein database, Drosophila melanogaster (Fruit fly: SwissProt Tax ID=7227); enzyme name, trypsin (full); maximum number of missed cleavages, 2; dynamic modification, oxidation (methionine), phosphorylation (serine, threonine, tyrosine), acetyl (lysine), GG (lysine); N-terminal modification, Met-loss (methionine), and Met-loss+acetyl (methionine); static modification, carbamidomethylation (cysteine) and FDR confidence, High &lt; 0.01, 0.01 ≤ Medium &lt; 0.05, 0.05 ≤ Low. The parameters for LFQ were as follows: precursor abundance, based on area; and normalization mode, total peptide amount.</p>
<p>The abundance ratio of <italic>milton</italic> RNAi to control RNAi at 7- or 21-day-old was calculated. We considered proteins with an abundance ratio of ≥2.0 or ≤ 0.5 and an ANOVA <italic>P</italic>-value of &lt; 0.05 based on volcano plots to be differentially expressed of <italic>milton</italic> RNAi. To extract molecular networks biologically relevant to the proteins that are differentially expressed in <italic>milton</italic> RNAi, pathway analysis was performed using KeyMolnet (KM Data Inc., Tokyo, Japan).</p>
</sec>
</sec>
<sec id="s4h">
<title>RNA extraction and quantitative real-time PCR analysis</title>
<p>Heads from more than 25 flies were mechanically isolated, and total RNA was extracted using ISOGEN (NipponGene) followed by reverse-transcription using PrimeScript RT reagent kit (Takara). The resulting cDNA was used as a template for PCR with THUNDERBIRD SYBR qPCR mix (TOYOBO) on a Thermal Cycler Dice real-time system TP800 (Takara). Expression of genes of interest was standardized relative to rp49. Relative expression values were determined by the ΔΔCT method (Livak and Schmittgen, 2001). Experiments were repeated three times, and a representative result was shown.</p>
<p>Primers were designed using DRSC FlyPrimerBank (Harvard Medical School). Primer sequences are shown below;</p>
<p><italic>eIF2</italic>β for 5′-GGACGACGACAAGAGCGAAG -3′</p>
<p><italic>eIF2</italic>β rev 5′-CGGTCGCATCACGAACTTTG -3′</p>
<p><italic>milton</italic> for 5′-GGCTTCAGGGCCAGGTATCT-3′</p>
<p><italic>milton</italic> rev 5′-GCCGAACTTGGCTGACTTTG-3′</p>
<p><italic>Actin</italic> for 5′-TGCACCGCAAGTGCTTCTAA-3′</p>
<p><italic>Actin</italic> rev 5′-TGCTGCACTCCAAACTTCCA-3′</p>
<p><italic>rp49</italic> for 5′-GCTAAGCTGTCGCACAAATG-3′</p>
<p><italic>rp49</italic> rev 5′- GTTCGATCCGTAACCGATGT-3′</p>
</sec>
<sec id="s4i">
<title>Polysome gradient centrifugation</title>
<p>30 heads were homogenized in 150 µl of lysis buffer (25 mM Tris pH 7.5, 50 mM MgCl2, 250 mM NaCl, 1 mM DTT, 0.5 mg/ml cycloheximide, 0.1 mg/ml heparin). The lysates were centrifuged at 13,200 rpm at 4 °C for 5 minutes, and the supernatant was collected. The samples containing 38µg of RNA was layered gently on top of a 10–50% w/w sucrose gradient (50 mM Tris pH 7.5, 50 mM MgCl2, 250 mM NaCl, 0.1 mg/ml heparin, 0.5 mg/ml cycloheximide in 5 ml polyallomer tube) and centrifuged at 37,000 rpm at 4°C for 150 minutes in a himac CP-NX ultracentrifuge using a P50AT rotor. Samples were fractionated from top to bottom, and absorbance at OD260 nm was analyzed by a Plate reader (EnSpire). Experiments were repeated at least 3 times with independent cohorts of flies.</p>
</sec>
<sec id="s4j">
<title>Puromycin analysis</title>
<p>13-day-old flies were starved for 6 hr and fed 600 μM puromycin (Sigma) or 600 μM puromycin/35 mM cycloheximide (Sigma) in 5% sucrose solution for 20 hr. Incorporated puromycin was quantified by western blot with anti-puromycin antibody and normalized with actin. Experiments were repeated at least 3 times with independent cohorts of flies.</p>
</sec>
<sec id="s4k">
<title>Histological analysis</title>
<p>Fly heads were fixed in Bouin’s fixative solution for 48 h at room temperature, incubated for 24 h in 50 mM Tris/150 mM NaCl, and embedded in paraffin. Serial sections (7 μm thickness) through the entire heads were stained with hematoxylin and eosin and examined by bright-field microscopy. Images of the sections that include the lamina were captured with Keyence microscope BZ-X700 (Keyence), and the vacuole area was measured using ImageJ (National Institutes of Health).</p>
</sec>
<sec id="s4l">
<title>Climbing assay</title>
<p>The climbing assay was performed as previously described<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. Flies were placed in an empty plastic vial (2.5 cm in diameter × 10 cm in length). The vial was gently tapped to knock the flies to the bottom, and the number of flies reached to the top, middle and bottom areas of the vials in 10 s was counted. Experiments were repeated 10 times, and the mean percentage of flies in each area and standard deviations were calculated. Experiments were repeated with independent cohorts more than three times, and a representative result was shown.</p>
</sec>
<sec id="s4m">
<title>Statistics</title>
<p>The number of replicates, what n represents, precision measurements, and the meaning of error bars are indicated in Figure Legends. Data are shown as means ± SEM. For pairwise comparisons, Student’s t-test was performed with Microsoft Excel (Microsoft). For multiple comparisons, data were analyzed using one-way ANOVA with Tukey’s HSD multiple-comparisons test in the GraphPad Prism 6.0 software (GraphPad Software, Inc., La Jolla, CA). Results with a p-value of less than 0.05 were considered to be statistically significant.</p>
</sec>
</sec>

</body>
<back>
<sec id="das" sec-type="data-availability">
<title>Data availability</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author upon request.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>The authors thank the Bloomington stock center; TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947); the Kyoto Drosophila Stock Center and the Vienna Drosophila RNAi Center for fly stocks. The authors thank Dr. Masayuki Miura from Department of Pharmaceutical Science, University of Tokyo, for proteasome activity assay protocol; Dr. Shin-ichi Hisanaga from the Department of Biological Sciences, Tokyo Metropolitan University, for critical comments; Dr. Taro Saito, Dr. Akiko Asada from the Department of Biological Sciences, Tokyo Metropolitan University, Dr. Michiko Sekiya from Department of Alzheimer’s Disease Research, National Center for Geriatrics and Gerontology, and Dr. Seiji Watanabe, Dr. Koji Yamanaka from Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University for technical supports.</p>
</ack>
<sec id="additional-info" sec-type="additional-information">
<title>Additional information</title>
<sec id="s5">
<title>Funding</title>
<p>This work was supported by the Sasakawa Scientific Research Grant (2021-4087) (to K.S.), the Takeda Science Foundation (to KA), Hoansha foundation grant (to KA), a research award from the Japan Foundation for Aging and Health (to KA), the Novartis Foundation (Japan) for the promotion of Science (to KA), JSPS KAKENHI Grant-in-Aid for Scientific Research on Challenging Research (Exploratory) JP19K21593 (to KA), JSPS KAKENHI Grant-in-Aid for Scientific Research(B) JP24K02860 (to KA), NIG-JOINT (National Institute of Genetics, 71A2018, 25A2019) (to K.A.) and TMU strategic research fund for social engagement (to KA).</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>K.S. and K.A. designed the experiments, interpreted the data, and wrote the manuscript; K.S., Y.M., K.M.I and E.S. conducted the experiments, and K.S., Y.M., E.S., and K.A. analyzed the data. All authors read and approved the manuscript.</p>
</sec>
</sec>
<sec id="additional-files" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="supp1">
<label>Table S1, Table S2</label>
<media xlink:href="supplements/576435_file11.xlsx"/>
</supplementary-material>
<supplementary-material id="supp2">
<label>Figure S1.</label>
<caption>
<title>Ubiquitinated proteins in brains with neuronal knockdown of <italic>milton</italic> at 1-day-old.</title>
<p>Brains dissected at 1-day-old were immunostained with an antibody against ubiquitin. Representative images (left) and quantitation of the number of ubiquitin-positive puncta (right) are shown. Scale bars of hemibrains, 100 µm, Means ± SE, n = 8. <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05 (Student’s <italic>t</italic>-test).</p>
</caption>
<media xlink:href="supplements/576435_file12.tif"/>
</supplementary-material>
<supplementary-material id="supp3">
<label>Figure S2.</label>
<caption>
<title>Histology analysis of fly heads with <italic>eIF2</italic>β overexpression.</title>
<p>The morphology of the eye with eIF2β overexpression. The dotted lines indicate the retina. Vacuoles are indicated by arrows. Representative images (left) and quantification of vacuole area (right). The flies were 40-day-old. Means ± SE, n = 5-13 <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05 (Student’s <italic>t</italic>-test).</p>
</caption>
<media xlink:href="supplements/576435_file13.tif"/>
</supplementary-material>
<supplementary-material id="supp4">
<label>Figure S3.</label>
<caption>
<title>Lowering the eIF2β level does not affect the levels of eIF2α and p-eIF2α.</title>
<p>(A, B) Blotting was performed with anti-eIF2α (A) and anti-p-eIF2α (B) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n = 6. (C) <italic>eIF2</italic>β gene disruption does not affect the knockdown efficiency of <italic>milton</italic>. <italic>milton</italic> mRNA levels in head extracts were quantified by qRT-PCR. Flies were 2-day-old. Means ± SE, n = 3. <italic>N.S.</italic>, <italic>p</italic> &gt; 0.05; *<italic>p</italic> &lt; 0.05 (Student’s <italic>t</italic>-test).</p>
</caption>
<media xlink:href="supplements/576435_file05.tif"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yerbury</surname>, <given-names>J.J.</given-names></string-name>, <string-name><surname>Ooi</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Dillin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Saunders</surname>, <given-names>D.N.</given-names></string-name>, <string-name><surname>Hatters</surname>, <given-names>D.M.</given-names></string-name>, <string-name><surname>Beart</surname>, <given-names>P.M.</given-names></string-name>, <string-name><surname>Cashman</surname>, <given-names>N.R.</given-names></string-name>, <string-name><surname>Wilson</surname>, <given-names>M.R.</given-names></string-name>, and <string-name><surname>Ecroyd</surname>, <given-names>H</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Walking the tightrope: proteostasis and neurodegenerative disease</article-title>. <source>J. Neurochem</source>. <volume>137</volume>, <fpage>489</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13575</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hetz</surname>, <given-names>C</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Adapting the proteostasis capacity to sustain brain healthspan</article-title>. <source>Cell</source> <volume>184</volume>, <fpage>1545</fpage>–<lpage>1560</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2021.02.007</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balch</surname>, <given-names>W.E.</given-names></string-name>, <string-name><surname>Morimoto</surname>, <given-names>R.I.</given-names></string-name>, <string-name><surname>Dillin</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Kelly</surname>, <given-names>J.W</given-names></string-name></person-group>. (<year>2008</year>). <article-title>Adapting proteostasis for disease intervention</article-title>. <source>Science</source> <volume>319</volume>, <fpage>916</fpage>–<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1126/science.1141448</pub-id>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kimball</surname>, <given-names>S.R</given-names></string-name></person-group>. (<year>1999</year>). <article-title>Eukaryotic initiation factor eIF2</article-title>. <source>Int J Biochem Cell Biol</source> <volume>31</volume>, <fpage>25</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/s1357-2725(98)00128-9</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jackson</surname>, <given-names>R.J.</given-names></string-name>, <string-name><surname>Hellen</surname>, <given-names>C.U.</given-names></string-name>, and <string-name><surname>Pestova</surname>, <given-names>T.V</given-names></string-name></person-group>. (<year>2010</year>). <article-title>The mechanism of eukaryotic translation initiation and principles of its regulation</article-title>. <source>Nat. Rev. Mol. Cell Biol</source>. <volume>11</volume>, <fpage>113</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2838</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pakos-Zebrucka</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Koryga</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Mnich</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ljujic</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Samali</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Gorman</surname>, <given-names>A.M</given-names></string-name></person-group>. (<year>2016</year>). <article-title>The integrated stress response</article-title>. <source>EMBO Rep</source> <volume>17</volume>, <fpage>1374</fpage>–<lpage>1395</lpage>. <pub-id pub-id-type="doi">10.15252/embr.201642195</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kroemer</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Marino</surname>, <given-names>G.</given-names></string-name>, and <string-name><surname>Levine</surname>, <given-names>B</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Autophagy and the integrated stress response</article-title>. <source>Mol. Cell</source> <volume>40</volume>, <fpage>280</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.023</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nandi</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Tahiliani</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Kumar</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Chandu</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2006</year>). <article-title>The ubiquitin-proteasome system</article-title>. <source>J Biosci</source> <volume>31</volume>, <fpage>137</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1007/BF02705243</pub-id>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Glick</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Barth</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Macleod</surname>, <given-names>K.F</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Autophagy: cellular and molecular mechanisms</article-title>. <source>J. Pathol</source>. <volume>221</volume>, <fpage>3</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1002/path.2697</pub-id>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vargas</surname>, <given-names>J.N.S.</given-names></string-name>, <string-name><surname>Hamasaki</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kawabata</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Youle</surname>, <given-names>R.J.</given-names></string-name>, and <string-name><surname>Yoshimori</surname>, <given-names>T</given-names></string-name></person-group>. (<year>2023</year>). <article-title>The mechanisms and roles of selective autophagy in mammals</article-title>. <source>Nat. Rev. Mol. Cell Biol</source>. <volume>24</volume>, <fpage>167</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-022-00542-2</pub-id>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aman</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Schmauck-Medina</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hansen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Morimoto</surname>, <given-names>R.I.</given-names></string-name>, <string-name><surname>Simon</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Bjedov</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Palikaras</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Simonsen</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Johansen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tavernarakis</surname>, <given-names>N.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>Autophagy in healthy aging and disease</article-title>. <source>Nat Aging</source> <volume>1</volume>, <fpage>634</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1038/s43587-021-00098-4</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ross</surname>, <given-names>C.A.</given-names></string-name>, and <string-name><surname>Poirier</surname>, <given-names>M.A</given-names></string-name></person-group>. (<year>2004</year>). <article-title>Protein aggregation and neurodegenerative disease</article-title>. <source>Nat. Med</source>. <volume>10</volume> <issue>Suppl</issue>, <fpage>S10</fpage>-<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1038/nm1066</pub-id>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rubinsztein</surname>, <given-names>D.C.</given-names></string-name>, <string-name><surname>Marino</surname>, <given-names>G.</given-names></string-name>, and <string-name><surname>Kroemer</surname>, <given-names>G</given-names></string-name></person-group>. (<year>2011</year>). <article-title>Autophagy and aging</article-title>. <source>Cell</source> <volume>146</volume>, <fpage>682</fpage>–<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.07.030</pub-id>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vos</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lauwers</surname>, <given-names>E.</given-names></string-name>, and <string-name><surname>Verstreken</surname>, <given-names>P</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease</article-title>. <source>Front Synaptic Neurosci</source> <volume>2</volume>, <issue>139</issue>. <pub-id pub-id-type="doi">10.3389/fnsyn.2010.00139</pub-id>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hou</surname>, <given-names>Y.</given-names></string-name>, and <string-name><surname>Mattson</surname>, <given-names>M.P</given-names></string-name></person-group>. (<year>2010</year>). <article-title>Mitochondria and neuroplasticity</article-title>. <source>ASN Neuro</source> <volume>2</volume>, <fpage>e00045</fpage>. <pub-id pub-id-type="doi">10.1042/AN20100019</pub-id>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hollenbeck</surname>, <given-names>P.J.</given-names></string-name>, and <string-name><surname>Saxton</surname>, <given-names>W.M</given-names></string-name></person-group>. (<year>2005</year>). <article-title>The axonal transport of mitochondria</article-title>. <source>J. Cell Sci</source>. <volume>118</volume>, <fpage>5411</fpage>–<lpage>5419</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.02745</pub-id>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takihara</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Inatani</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Eto</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Inoue</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kreymerman</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Miyake</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ueno</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Nagaya</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nakanishi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Iwao</surname>, <given-names>K.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2015</year>). <article-title>In vivo imaging of axonal transport of mitochondria in the diseased and aged mammalian CNS</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>112</volume>, <fpage>10515</fpage>–<lpage>10520</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1509879112</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Milde</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Adalbert</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Elaman</surname>, <given-names>M.H.</given-names></string-name>, and <string-name><surname>Coleman</surname>, <given-names>M.P</given-names></string-name></person-group>. (<year>2015</year>). <article-title>Axonal transport declines with age in two distinct phases separated by a period of relative stability</article-title>. <source>Neurobiol. Aging</source> <volume>36</volume>, <fpage>971</fpage>–<lpage>981</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.09.018</pub-id>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vagnoni</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hoffmann</surname>, <given-names>P.C.</given-names></string-name>, and <string-name><surname>Bullock</surname>, <given-names>S.L</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Reducing Lissencephaly-1 levels augments mitochondrial transport and has a protective effect in adult Drosophila neurons</article-title>. <source>J. Cell Sci</source>. <volume>129</volume>, <fpage>178</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.179184</pub-id>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morsci</surname>, <given-names>N.S.</given-names></string-name>, <string-name><surname>Hall</surname>, <given-names>D.H.</given-names></string-name>, <string-name><surname>Driscoll</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Sheng</surname>, <given-names>Z.H</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Age-Related Phasic Patterns of Mitochondrial Maintenance in Adult Caenorhabditis elegans Neurons</article-title>. <source>J. Neurosci</source>. <volume>36</volume>, <fpage>1373</fpage>–<lpage>1385</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2799-15.2016</pub-id>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adalbert</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Coleman</surname>, <given-names>M.P</given-names></string-name></person-group>. (<year>2013</year>). <article-title>Review: Axon pathology in age-related neurodegenerative disorders</article-title>. <source>Neuropathol. Appl. Neurobiol</source>. <volume>39</volume>, <fpage>90</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2990.2012.01308.x</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Duncan</surname>, <given-names>J.E.</given-names></string-name>, and <string-name><surname>Goldstein</surname>, <given-names>L.S</given-names></string-name></person-group>. (<year>2006</year>). <article-title>The genetics of axonal transport and axonal transport disorders</article-title>. <source>PLoS Genet</source>. <volume>2</volume>, <fpage>e124</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0020124</pub-id>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Chan</surname>, <given-names>D.C</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases</article-title>. <source>Hum. Mol. Genet</source>. <volume>18</volume>, <fpage>R169</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp326</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iijima-Ando</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Sekiya</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Maruko-Otake</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ohtake</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Suzuki</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>B.</given-names></string-name>, and <string-name><surname>Iijima</surname>, <given-names>K.M</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer’s disease-related tau phosphorylation via PAR-1</article-title>. <source>PLoS Genet</source>. <volume>8</volume>, <fpage>e1002918</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002918</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lopez-Domenech</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Higgs</surname>, <given-names>N.F.</given-names></string-name>, <string-name><surname>Vaccaro</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Ros</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Arancibia-Carcamo</surname>, <given-names>I.L.</given-names></string-name>, <string-name><surname>MacAskill</surname>, <given-names>A.F.</given-names></string-name>, and <string-name><surname>Kittler</surname>, <given-names>J.T</given-names></string-name></person-group>. (<year>2016</year>). <article-title>Loss of Dendritic Complexity Precedes Neurodegeneration in a Mouse Model with Disrupted Mitochondrial Distribution in Mature Dendrites</article-title>. <source>Cell Rep</source> <volume>17</volume>, <fpage>317</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.004</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Macleod</surname>, <given-names>G.T.</given-names></string-name>, <string-name><surname>Wellington</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Panchumarthi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Schoenfield</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Marin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Charlton</surname>, <given-names>M.P.</given-names></string-name>, <string-name><surname>Atwood</surname>, <given-names>H.L.</given-names></string-name>, and <string-name><surname>Zinsmaier</surname>, <given-names>K.E</given-names></string-name></person-group>. (<year>2005</year>). <article-title>The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses</article-title>. <source>Neuron</source> <volume>47</volume>, <fpage>379</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.06.027</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Glater</surname>, <given-names>E.E.</given-names></string-name>, <string-name><surname>Megeath</surname>, <given-names>L.J.</given-names></string-name>, <string-name><surname>Stowers</surname>, <given-names>R.S.</given-names></string-name>, and <string-name><surname>Schwarz</surname>, <given-names>T.L</given-names></string-name></person-group>. (<year>2006</year>). <article-title>Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent</article-title>. <source>J. Cell Biol</source>. <volume>173</volume>, <fpage>545</fpage>–<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200601067</pub-id>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stowers</surname>, <given-names>R.S.</given-names></string-name>, <string-name><surname>Megeath</surname>, <given-names>L.J.</given-names></string-name>, <string-name><surname>Gorska-Andrzejak</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Meinertzhagen</surname>, <given-names>I.A.</given-names></string-name>, and <string-name><surname>Schwarz</surname>, <given-names>T.L</given-names></string-name></person-group>. (<year>2002</year>). <article-title>Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein</article-title>. <source>Neuron</source> <volume>36</volume>, <fpage>1063</fpage>–<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(02)01094-2</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iijima-Ando</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hearn</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Shenton</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gatt</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Iijima</surname>, <given-names>K</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer’s disease</article-title>. <source>PLoS One</source> <volume>4</volume>, <fpage>e8310</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0008310</pub-id>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tonoki</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kuranaga</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Tomioka</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Hamazaki</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Murata</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tanaka</surname>, <given-names>K.</given-names></string-name>, and <string-name><surname>Miura</surname>, <given-names>M</given-names></string-name></person-group>. (<year>2009</year>). <article-title>Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process</article-title>. <source>Mol. Cell. Biol</source>. <volume>29</volume>, <fpage>1095</fpage>–<lpage>1106</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.01227-08</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klionsky</surname>, <given-names>D.J.</given-names></string-name>, <string-name><surname>Abdel-Aziz</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Abdelfatah</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Abdellatif</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Abdoli</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Abel</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Abeliovich</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Abildgaard</surname>, <given-names>M.H.</given-names></string-name>, <string-name><surname>Abudu</surname>, <given-names>Y.P.</given-names></string-name>, <string-name><surname>Acevedo-Arozena</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2021</year>). <article-title>Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1)</article-title>. <source>Autophagy</source> <volume>17</volume>, <fpage>1</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2020.1797280</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bartlett</surname>, <given-names>B.J.</given-names></string-name>, <string-name><surname>Isakson</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lewerenz</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sanchez</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kotzebue</surname>, <given-names>R.W.</given-names></string-name>, <string-name><surname>Cumming</surname>, <given-names>R.C.</given-names></string-name>, <string-name><surname>Harris</surname>, <given-names>G.L.</given-names></string-name>, <string-name><surname>Nezis</surname>, <given-names>I.P.</given-names></string-name>, <string-name><surname>Schubert</surname>, <given-names>D.R.</given-names></string-name>, <string-name><surname>Simonsen</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Finley</surname>, <given-names>K.D</given-names></string-name></person-group>. (<year>2011</year>). <article-title>p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects</article-title>. <source>Autophagy</source> <volume>7</volume>, <fpage>572</fpage>–<lpage>583</lpage>. <pub-id pub-id-type="doi">10.4161/auto.7.6.14943</pub-id>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oka</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Suzuki</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Asada</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Saito</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Iijima</surname>, <given-names>K.M.</given-names></string-name>, and <string-name><surname>Ando</surname>, <given-names>K.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Increasing neuronal glucose uptake attenuates brain aging and promotes life span under dietary restriction in Drosophila</article-title>. <source>iScience</source> <volume>24</volume>, <issue>101979</issue>. <pub-id pub-id-type="doi">10.1016/j.isci.2020.101979</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zia</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Pourbagher-Shahri</surname>, <given-names>A.M.</given-names></string-name>, <string-name><surname>Farkhondeh</surname>, <given-names>T.</given-names></string-name>, and <string-name><surname>Samarghandian</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Molecular and cellular pathways contributing to brain aging</article-title>. <source>Behav Brain Funct</source> <volume>17</volume>, <issue>6</issue>. <pub-id pub-id-type="doi">10.1186/s12993-021-00179-9</pub-id>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Haigis</surname>, <given-names>M.C.</given-names></string-name>, and <string-name><surname>Yankner</surname>, <given-names>B.A</given-names></string-name></person-group>. (<year>2010</year>). <article-title>The aging stress response</article-title>. <source>Mol. Cell</source> <volume>40</volume>, <fpage>333</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.10.002</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wek</surname>, <given-names>R.C</given-names></string-name></person-group>. (<year>2018</year>). <article-title>Role of eIF2alpha Kinases in Translational Control and Adaptation to Cellular Stress</article-title>. <source>Cold Spring Harb Perspect Biol</source> <volume>10</volume>. <pub-id pub-id-type="doi">10.1101/cshperspect.a032870</pub-id>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Currais</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fischer</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Maher</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Schubert</surname>, <given-names>D</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain</article-title>. <source>FASEB J</source>. <volume>31</volume>, <fpage>5</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201601184</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grimm</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Eckert</surname>, <given-names>A</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Brain aging and neurodegeneration: from a mitochondrial point of view</article-title>. <source>J. Neurochem</source>. <volume>143</volume>, <fpage>418</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.14037</pub-id>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bond</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lopez-Lloreda</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gannon</surname>, <given-names>P.J.</given-names></string-name>, <string-name><surname>Akay-Espinoza</surname>, <given-names>C.</given-names></string-name>, and <string-name><surname>Jordan-Sciutto</surname>, <given-names>K.L</given-names></string-name></person-group>. (<year>2020</year>). <article-title>The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2alpha in Neurodegeneration</article-title>. <source>J. Neuropathol. Exp. Neurol</source>. <volume>79</volume>, <fpage>123</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/nlz129</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>B’Chir</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Maurin</surname>, <given-names>A.C.</given-names></string-name>, <string-name><surname>Carraro</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Averous</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Jousse</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Muranishi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Parry</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Stepien</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Fafournoux</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Bruhat</surname>, <given-names>A</given-names></string-name></person-group>. (<year>2013</year>). <article-title>The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression</article-title>. <source>Nucleic Acids Res</source>. <volume>41</volume>, <fpage>7683</fpage>–<lpage>7699</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt563</pub-id>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salton</surname>, <given-names>G.D.</given-names></string-name>, <string-name><surname>Laurino</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Mega</surname>, <given-names>N.O.</given-names></string-name>, <string-name><surname>Delgado-Canedo</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Setterblad</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Carmagnat</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Xavier</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Cirne-Lima</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lenz</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Henriques</surname>, <given-names>J.A.P.</given-names></string-name>, and <string-name><surname>Laurino</surname>, <given-names>J.P</given-names></string-name></person-group>. (<year>2017</year>). <article-title>Deletion of eIF2beta lysine stretches creates a dominant negative that affects the translation and proliferation in human cell line: A tool for arresting the cell growth</article-title>. <source>Cancer Biol Ther</source> <volume>18</volume>, <fpage>560</fpage>–<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1080/15384047.2017.1345383</pub-id>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Nahm</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kwon</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Zadeh</surname>, <given-names>A.D.</given-names></string-name>, <string-name><surname>Cao</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>Z.H.</given-names></string-name>, <string-name><surname>Oh</surname>, <given-names>S.B.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2007</year>). <article-title>The F-actin-microtubule crosslinker Shot is a platform for Krasavietz-mediated translational regulation of midline axon repulsion</article-title>. <source>Development</source> <volume>134</volume>, <fpage>1767</fpage>–<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02842</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Tantray</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Lim</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Sitron</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Dong</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Gispert</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Auburger</surname>, <given-names>G.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2019</year>). <article-title>MISTERMINATE Mechanistically Links Mitochondrial Dysfunction with Proteostasis Failure</article-title>. <source>Mol. Cell</source> <volume>75</volume>, <fpage>835</fpage>–<lpage>848.e838.</lpage> <pub-id pub-id-type="doi">10.1016/j.molcel.2019.06.031</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sugiura</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Nagashima</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tokuyama</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Amo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Matsuki</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ishido</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kudo</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>McBride</surname>, <given-names>H.M.</given-names></string-name>, <string-name><surname>Fukuda</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Matsushita</surname>, <given-names>N.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2013</year>). <article-title>MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2</article-title>. <source>Mol. Cell</source> <volume>51</volume>, <fpage>20</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2013.04.023</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yonashiro</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Kimijima</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shimura</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kawaguchi</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Fukuda</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Inatome</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Yanagi</surname>, <given-names>S</given-names></string-name></person-group>. (<year>2012</year>). <article-title>Mitochondrial ubiquitin ligase MITOL blocks S-nitrosylated MAP1B-light chain 1-mediated mitochondrial dysfunction and neuronal cell death</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>109</volume>, <fpage>2382</fpage>–<lpage>2387</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1114985109</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takeda</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Nagashima</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shiiba</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Uda</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tokuyama</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Ito</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Fukuda</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Matsushita</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ishido</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Iwawaki</surname>, <given-names>T.</given-names></string-name>, <etal>et al.</etal></person-group> (<year>2019</year>). <article-title>MITOL prevents ER stress-induced apoptosis by IRE1alpha ubiquitylation at ER-mitochondria contact sites</article-title>. <source>EMBO J</source>. <volume>38</volume>, <fpage>e100999</fpage>. <pub-id pub-id-type="doi">10.15252/embj.2018100999</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.95576.4.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Frost</surname>
<given-names>Adam</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of California, San Francisco (Adjunct)</institution>
</institution-wrap>
<city>San Francisco</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Useful</kwd>
</kwd-group>
</front-stub>
<body>
<p>In flies defective for axonal transport of mitochondria, the authors report the upregulation of one subunit, the beta subunit, of the heterotrimeric eIF2 complex via mass spectroscopy proteomics. Neuronal overexpression of eIF2β phenocopied aspects of neuronal dysfunction observed when axonal transport of mitochondria was compromised. Conversely, lowering eIF2β expression suppressed aspects of neuronal dysfunction. While these are intriguing and <bold>useful</bold> observations, technical weaknesses limit the interpretation. On balance, the evidence supporting the current claims is suggestive but <bold>incomplete</bold>, especially concerning the characterization of the eIF2 heterotrimer and the data regarding translational regulation.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.95576.4.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The study presents significant findings on the role of mitochondrial depletion in axons and its impact on neuronal proteostasis. It effectively demonstrates how the loss of axonal mitochondria and elevated levels of eIF2β contribute to autophagy collapse and neuronal dysfunction. The use of Drosophila as a model organism and comprehensive proteome analysis adds robustness to the findings.</p>
<p>In this revision, the authors have responded thoughtfully to previous concerns. In particular, they have addressed the need for a quantitative analysis of age-dependent changes in eIF2β and eIF2α. By adding western blot data from multiple time points (7 to 63 days), they show that eIF2β levels gradually increase until middle age, then decline. In milton knockdown flies, this pattern appears shifted, supporting the idea that mitochondrial defects may accelerate aging-related molecular changes. These additions clarify the temporal dynamics of eIF2β and improve the overall interpretation.</p>
<p>Other updates include appropriate corrections to figures and quantification methods. The authors have also revised some of their earlier mechanistic claims, presenting a more cautious interpretation of their findings.</p>
<p>Overall, this work provides new insights into how mitochondrial transport defects may influence aging-related proteostasis through eIF2β. The manuscript is now more convincing, and the revisions address the main points raised earlier. I find the updated version much improved.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.95576.4.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In the manuscript, the authors aimed to elucidate the molecular mechanism that explains neurodegeneration caused by the depletion of axonal mitochondria. In Drosophila, starting with siRNA depletion of milton and Miro, the authors attempted to demonstrate that the depletion of axonal mitochondria induces the defect in autophagy. From proteome analyses, the authors hypothesized that autophagy is impacted by the abundance of eIF2β and the phosphorylation of eIF2α. The authors followed up the proteome analyses by testing the effects of eIF2β overexpression and depletion on autophagy. With the results from those experiments, the authors proposed a novel role of eIF2β in proteostasis that underlies neurodegeneration derived from the depletion of axonal mitochondria, which they suggest accelerates age-dependent changes rather than increasing their magnitude.</p>
<p>Strong caution is necessary regarding the interpretation of translational regulation resulting from the milton KD. The effect of milton KD on translation appears subtle, if present at all, in the puromycin incorporation experiments in both the initial and revised versions. Additionally, the polysome profiling data in the revised manuscript lack the clear resolution for ribosomal subunits, monosomes, and polysomes that is typically expected in publications.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.95576.4.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shinno</surname>
<given-names>Kanako</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0002-7114-7686</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Miura</surname>
<given-names>Yuri</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iijima</surname>
<given-names>Koichi M</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suzuki</surname>
<given-names>Emiko</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ando</surname>
<given-names>Kanae</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3956-276X</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the previous reviews</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Public review):</bold></p>
<p>The study presents significant findings on the role of mitochondrial depletion in axons and its impact on neuronal proteostasis. It effectively demonstrates how the loss of axonal mitochondria and elevated levels of eIF2β contribute to autophagy collapse and neuronal dysfunction. The use of Drosophila as a model organism and comprehensive proteome analysis adds robustness to the findings.</p>
<p>In this revision, the authors have responded thoughtfully to previous concerns. In particular, they have addressed the need for a quantitative analysis of age-dependent changes in eIF2β and eIF2α. By adding western blot data from multiple time points (7 to 63 days), they show that eIF2β levels gradually increase until middle age, then decline. In milton knockdown flies, this pattern appears shifted, supporting the idea that mitochondrial defects may accelerate aging-related molecular changes. These additions clarify the temporal dynamics of eIF2β and improve the overall interpretation.</p>
<p>Other updates include appropriate corrections to figures and quantification methods. The authors have also revised some of their earlier mechanistic claims, presenting a more cautious interpretation of their findings.</p>
<p>Overall, this work provides new insights into how mitochondrial transport defects may influence aging-related proteostasis through eIF2β. The manuscript is now more convincing, and the revisions address the main points raised earlier. I find the updated version much improved.</p>
</disp-quote>
<p>Thank you so much for the review, insightful comments and encouragement. We appreciate it.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public review):</bold></p>
<p>In the manuscript, the authors aimed to elucidate the molecular mechanism that explains neurodegeneration caused by the depletion of axonal mitochondria. In Drosophila, starting with siRNA depletion of milton and Miro, the authors attempted to demonstrate that the depletion of axonal mitochondria induces the defect in autophagy. From proteome analyses, the authors hypothesized that autophagy is impacted by the abundance of eIF2β and the phosphorylation of eIF2α. The authors followed up the proteome analyses by testing the effects of eIF2β overexpression and depletion on autophagy. With the results from those experiments, the authors proposed a novel role of eIF2β in proteostasis that underlies neurodegeneration derived from the depletion of axonal mitochondria, which they suggest accelerates age-dependent changes rather than increasing their magnitude.</p>
<p>Strong caution is necessary regarding the interpretation of translational regulation resulting from the milton KD. The effect of milton KD on translation appears subtle, if present at all, in the puromycin incorporation experiments in both the initial and revised versions. Additionally, the polysome profiling data in the revised manuscript lack the clear resolution for ribosomal subunits, monosomes, and polysomes that is typically expected in publications.</p>
</disp-quote>
<p>Thank you so much for the review and insightful comments. We appreciate it.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations for the authors):</bold></p>
<p>The revised manuscript demonstrates many improvements. The authors have provided a more comprehensive data set and a more detailed description of their results. Furthermore, their explanation of the Integrated Stress Response (ISR) has been corrected, and this correction is reflected in the data interpretation.</p>
<p>As in the public review, I maintained my emphasis on the weakness of the claim on suppressed global translation, since the data are the same in the initial and the revised versions.</p>
</disp-quote>
<p>Thank you for your review. We understand that further studies will be needed to elucidate the roles on mitochondrial distribution in global translation profile. We will keep working on it.</p>
<disp-quote content-type="editor-comment">
<p>A few suggestions for minor corrections.</p>
<p>(1) The order of figures in the revised version is disorganized.</p>
</disp-quote>
<p>Thank you for pointing it out. We corrected the order.</p>
<disp-quote content-type="editor-comment">
<p>(2) In Figure 1A, mitochondria is bound by milton, and kinesin is bound by Miro. Their roles should be opposite.</p>
</disp-quote>
<p>Thank you for pointing it out, and we are sorry for the oversight. We corrected it.</p>
</body>
</sub-article>
</article>